Laboratorios Farmaceuticos ROVI SA
MAD:ROVI

Watchlist Manager

Laboratorios Farmaceuticos ROVI SA

MAD:ROVI

Watchlist

Dividends

Discount Rate

Price: 65.2 EUR -0.31% Market Closed

Market Cap: 3.2B EUR

Have any thoughts about
Laboratorios Farmaceuticos ROVI SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 65.2 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ROVI Alert

Laboratorios Farmaceuticos ROVI SA

65.2

-0.2 (-0.31%)

52 Week Range	49.96 91.5
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Laboratorios Farmaceuticos ROVI SA

What unique competitive advantages
does Laboratorios Farmaceuticos ROVI SA hold over its rivals?

What risks and challenges
does Laboratorios Farmaceuticos ROVI SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Laboratorios Farmaceuticos ROVI SA.

What unique competitive advantages
does Laboratorios Farmaceuticos ROVI SA hold over its rivals?

What risks and challenges
does Laboratorios Farmaceuticos ROVI SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Laboratorios Farmaceuticos ROVI SA.

Provide P/S
for Laboratorios Farmaceuticos ROVI SA.

Provide P/E
for Laboratorios Farmaceuticos ROVI SA.

Provide P/OCF
for Laboratorios Farmaceuticos ROVI SA.

Provide P/FCFE
for Laboratorios Farmaceuticos ROVI SA.

Provide P/B
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/S
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/GP
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/EBITDA
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/EBIT
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/OCF
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/FCFF
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/IC
for Laboratorios Farmaceuticos ROVI SA.

Show me price targets
for Laboratorios Farmaceuticos ROVI SA made by professional analysts.

What are the Revenue projections
for Laboratorios Farmaceuticos ROVI SA?

How accurate were the past Revenue estimates
for Laboratorios Farmaceuticos ROVI SA?

What are the Net Income projections
for Laboratorios Farmaceuticos ROVI SA?

How accurate were the past Net Income estimates
for Laboratorios Farmaceuticos ROVI SA?

What are the EPS projections
for Laboratorios Farmaceuticos ROVI SA?

How accurate were the past EPS estimates
for Laboratorios Farmaceuticos ROVI SA?

What are the EBIT projections
for Laboratorios Farmaceuticos ROVI SA?

How accurate were the past EBIT estimates
for Laboratorios Farmaceuticos ROVI SA?

Compare the revenue forecasts
for Laboratorios Farmaceuticos ROVI SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Laboratorios Farmaceuticos ROVI SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Laboratorios Farmaceuticos ROVI SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Laboratorios Farmaceuticos ROVI SA compared to its peers.

Compare the P/E ratios
of Laboratorios Farmaceuticos ROVI SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Laboratorios Farmaceuticos ROVI SA with its peers.

Analyze the financial leverage
of Laboratorios Farmaceuticos ROVI SA compared to its main competitors.

Show all profitability ratios
for Laboratorios Farmaceuticos ROVI SA.

Provide ROE
for Laboratorios Farmaceuticos ROVI SA.

Provide ROA
for Laboratorios Farmaceuticos ROVI SA.

Provide ROIC
for Laboratorios Farmaceuticos ROVI SA.

Provide ROCE
for Laboratorios Farmaceuticos ROVI SA.

Provide Gross Margin
for Laboratorios Farmaceuticos ROVI SA.

Provide Operating Margin
for Laboratorios Farmaceuticos ROVI SA.

Provide Net Margin
for Laboratorios Farmaceuticos ROVI SA.

Provide FCF Margin
for Laboratorios Farmaceuticos ROVI SA.

Show all solvency ratios
for Laboratorios Farmaceuticos ROVI SA.

Provide D/E Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide D/A Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Interest Coverage Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Altman Z-Score Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Quick Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Current Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Cash Ratio
for Laboratorios Farmaceuticos ROVI SA.

What is the historical Revenue growth
over the last 5 years for Laboratorios Farmaceuticos ROVI SA?

What is the historical Net Income growth
over the last 5 years for Laboratorios Farmaceuticos ROVI SA?

What is the current Free Cash Flow
of Laboratorios Farmaceuticos ROVI SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Laboratorios Farmaceuticos ROVI SA.

EV/EBITDA
Enterprise Value to EBITDA

Current

10.6

Median

13.7

Industry

Higher than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

Enterprise Value

3.4B EUR

EBITDA

285.8m EUR

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
ES		Laboratorios Farmaceuticos ROVI SA MAD:ROVI	3.4B EUR	12
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 459 134.4
US		Eli Lilly and Co NYSE:LLY	746.8B USD	48
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	3 846.3
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	24.4
US		Johnson & Johnson NYSE:JNJ	365.6B USD	12
US		Merck & Co Inc NYSE:MRK	249.1B USD	10.4
CH		Roche Holding AG SIX:ROG	208.5B CHF	10.2
CH		Novartis AG SIX:NOVN	181.2B CHF	10
UK		AstraZeneca PLC LSE:AZN	159.6B GBP	168.8
IE	E	Endo International PLC LSE:0Y5F	146B USD	234.4

				EBITDA Growth
ES		Laboratorios Farmaceuticos ROVI SA MAD:ROVI	Average EV/EBITDA: 437.6 12	56%
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 459 134.4	N/A
US		Eli Lilly and Co NYSE:LLY	48	194%
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	151%
DK		Novo Nordisk A/S CSE:NOVO B	24.4	86%
US		Johnson & Johnson NYSE:JNJ	12	13%
US		Merck & Co Inc NYSE:MRK	10.4	339%
CH		Roche Holding AG SIX:ROG	10.2	23%
CH		Novartis AG SIX:NOVN	10	8%
UK		AstraZeneca PLC LSE:AZN	168.8	60%
IE	E	Endo International PLC LSE:0Y5F	234.4	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

14.3

2-Years Forward

EV/EBITDA

3-Years Forward

EV/EBITDA

Laboratorios Farmaceuticos ROVI SA
MAD:ROVI

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Laboratorios Farmaceuticos ROVI SA MAD:ROVI

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Laboratorios Farmaceuticos ROVI SA
MAD:ROVI

EV/EBITDA
Enterprise Value to EBITDA